Among the tested KRAB-ZNFs, numerous studies demonstrate significant engagement of ZNF224 in the regulation of cancer development and progression, especially in melanoma [37], breast cancer [38,39], and Wilms tumor [40]. This evidence concerns the gene ZNF224 and melanoma.